ELDN stock

Eledon Pharmaceuticals Inc (ELDN) financials · $209.6M cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Eledon Pharmaceuticals Inc (ELDN) $209.6M cap.

Cached annual income statement
LineFY2025FY2024
Net Income-$45.6M-$36.2M
EPS (Diluted)-$0.52-$0.75
Cached annual balance sheet
LineFY2025FY2024
Total Assets$169.0M$177.4M
Current Assets$135.7M$143.7M
Cash & Equivalents$22.8M$20.5M
Total Liabilities$32.2M$59.3M
Current Liabilities$18.3M$11.6M
Shareholders' Equity$81.1M$118.1M
Retained Earnings-$401.2M-$355.6M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$62.3M-$47.3M
Investing Cash Flow$10.8M-$70.3M
Financing Cash Flow$53.8M$133.5M
Net Change in Cash$2.26M$15.9M
These statements as JSON? API free 100/day

FAQ

What is ELDN P/E and revenue?

Eledon Pharmaceuticals Inc (ELDN) $209.6M cap.

What is ELDN revenue?

ELDN income-statement cache has no revenue figure yet.

Is ELDN profitable?

Eledon Pharmaceuticals Inc last cached net income is -$45.6M (FY2025).

What are ELDN total assets?

Eledon Pharmaceuticals Inc last cached total assets are $169.0M (FY2025).

What is ELDN free cash flow?

No cached cash-flow row for ELDN yet.

Not investment advice. Cached statements, not a live tape.